Literature DB >> 22555039

Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: a survey by the Brazilian Society of Urology.

Aguinaldo Cesar Nardi1, Rodolfo Borges dos Reis, Stenio de Cassio Zequi, Archimedes Nardozza.   

Abstract

OBJECTIVE: To describe the epidemiological features and patterns of initial care for prostate cancer at public and private institutions in the State of Sao Paulo, Brazil.
MATERIALS AND METHODS: A total of 1,082 physicians affiliated to the Sao Paulo Section of the Brazilian Society of Urology were invited to participate in this cross-sectional, web-based survey. Between September 2004 and September 2005, participating urologists entered data on demographic, clinical and pathological characteristics of patients diagnosed with prostate cancer in their practice. Data on patients attended at public institutions were analyzed and compared with those patients attended at private practice.
RESULTS: One hundred and ten society members contributed with data from 1915 patients, 1026 (53.6%) of whom from public institutions. When compared with patients attended at private institutions, those attended at public institutions were older and more likely to be black, had higher serum prostate specific antigen (PSA) levels, had a higher probability of being diagnosed with metastatic disease, but were less likely to undergo prostatectomy (all P < 0.001). In multivariate analysis, age, biopsy Gleason score, and being attended at a public institution were independently associated with metastatic disease upon diagnosis. The significant predictors of nonsurgical treatment were age, black race, and higher serum levels of PSA.
CONCLUSIONS: A statewide registry provides valuable information regarding patient demographics, clinical features, and patterns of care. The results of this study suggest that significant disparities exist for patients with prostate cancer attended at different health-care systems. The relative contribution of biological versus socioeconomic features remains uncertain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555039     DOI: 10.1590/s1677-55382012000200003

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  8 in total

1.  Initial care and outcome of glioblastoma multiforme patients in 2 diverse health care scenarios in Brazil: does public versus private health care matter?.

Authors:  Luiz Victor Maia Loureiro; Lucíola de Barros Pontes; Donato Callegaro-Filho; Ludmila de Oliveira Koch; Eduardo Weltman; Elivane da Silva Victor; Adrialdo José Santos; Lia Raquel Rodrigues Borges; Roberto Araújo Segreto; Suzana Maria Fleury Malheiros
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

2.  Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.

Authors:  Renan A Pereira; Roberto S Costa; Valdair F Muglia; Fábio Franca Silva; Joyce S Lajes; Rodolfo B Dos Reis; Gyl Eb Silva
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

3.  Describing mortality trends for major cancer sites in 133 intermediate regions of Brazil and an ecological study of its causes.

Authors:  Alessandro Bigoni; José Leopoldo Ferreira Antunes; Elisabete Weiderpass; Kristina Kjærheim
Journal:  BMC Cancer       Date:  2019-10-11       Impact factor: 4.430

4.  Identifying quality of life indicators to improve outpatient pharmacy services for prostate cancer patients: a comparison between Brazilian and British experiences.

Authors:  Harindra Patel; Patrícia Melo Aguiar; Adalberto Pessoa; Sílvia Storpirtis; Paul F Long
Journal:  Int Braz J Urol       Date:  2019 May-Jun       Impact factor: 1.541

5.  Prostate Cancer in Latin America: Challenges and Recommendations.

Authors:  Rodolfo Borges Dos Reis; Alejandro Alías-Melgar; Andrés Martínez-Cornelio; Silvia P Neciosup; Juan Pablo Sade; Marcos Santos; Gustavo Martin Villoldo
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

6.  Prostate cancer screening among elderly men in Brazil: should we diagnose or not?

Authors:  Rafael Ribeiro Mori; Eliney Ferreira Faria; Edmundo Carvalho Mauad; Antonio Antunes Rodrigues; Rodolfo Borges Dos Reis
Journal:  Int Braz J Urol       Date:  2020 Jan-Feb       Impact factor: 1.541

7.  Cyclin D1 expression in prostate carcinoma.

Authors:  R A Pereira; R C Ravinal; R S Costa; M S Lima; S Tucci; V F Muglia; R B dos Reis; G E B Silva
Journal:  Braz J Med Biol Res       Date:  2014-05-02       Impact factor: 2.590

Review 8.  Prostate cancer in Brazil and Latin America: epidemiology and screening.

Authors:  Rafael Rocha Tourinho-Barbosa; Antonio Carlos Lima Pompeo; Sidney Glina
Journal:  Int Braz J Urol       Date:  2016 Nov-Dec       Impact factor: 1.541

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.